Background. Acid fast cell wall deficient forms (CWDF) of bacteria have been grown from blood
Sarcoidosis is a multisystem granulomatous disorder of
These infectious agents are known to be capable of stimulating the formation of granulomas and are unknown aetiology. As sarcoidosis commonly affects the lung and regional thoracic lymph nodes, it has been particulates which can be inhaled and ingested by macrophages. Some of these agents persist in tissue as postulated that a possible aetiological agent may enter the body through the inhaled route. Since its original a result of their resistance to intracellular bactericidal mechanisms or resistance to degradation because of their description, 1 many agents have been suggested as a cause for this disease but no firm consensus exists about physical characteristics. Although the most extensive research has focused on an infectious aetiology and, in the specific initiating antigen (box). particular, on mycobacterial infection, other possible antigens have been investigated. It is possible that there is more than one causal agent involved and that other factors such as genetic influences may also modulate Possible agents in the pathogenesis of the immune response in the pathogenesis of sarcoidosis. sarcoidosis This is supported by the high incidence of sarcoidosis
Mycobacterial infections
in siblings when compared with the population fre- 30 proposed that sarcoidosis should, in fact, be called "non-caseating tuberculosis" the skin of patients with sarcoidosis.
because of the similarities in histological appearance.
Evidence for an infective/transmissible agent
In support of the possibility of a transmissible agent      Depending on host factors, patients present clinically there has been a case report of pulmonary sarcoidosis developing in the recipient of a cardiac transplant from with a variety of responses to mycobacterial infection ranging from the pattern seen in immunocompromised a donor later found to have sarcoidosis at post-mortem examination.
14 There is a further report where sarsubjects where there are large numbers of organisms but little evidence of an immunological response to coidosis may have been transmitted through a bone marrow transplant. 15 Animal models have established subjects with no signs or symptoms of disease who, on the basis of their characteristic radiographs, skin that homogenates of human sarcoid tissue can induce characteristic granulomatous reactions. 16 17 These are reactivity and other immunological measures, have clearly been infected in the past. This group are thought discussed in greater detail later in this review.
to have small numbers of viable mycobacteria persisting in their tissues but these are not detectable by conventional means. It has been suggested that sarcoidosis Non-mycobacterial infective agents There have been sporadic reports of viral infections in may be a clinical manifestation of this group of patients with mycobacterial infection who have a strong granurelation to sarcoidosis. [18] [19] [20] There are frequently high titres of antibodies to a variety of viruses in patients lomatous response associated with good elimination of mycobacteria. 31 As a result of their efficiency in removal with sarcoidosis, but these findings may merely reflect B cell hyperresponsiveness with increased immunoof the mycobacteria, the detection of the organisms is difficult if not impossible. globulin synthesis. 21 It has also been suggested that mycobacterial and viral infections may interact and Clinically, there are instances when tuberculosis is diagnosed on the basis of typical radiographic and clinical produce sarcoidosis as a result of a virally induced defective T cell response to mycobacterial infection. presentation without bacteriological confirmation. The diagnosis of tuberculosis may also occur when tissue Uesaka et al 22 described the isolation of 17 organisms from tissue samples from 36 patients with sarcoidosis reveals caseating granulomas (this having also been described in sarcoidosis), also in the absence of positive and discovered that some of the organisms cultured from lymph nodes had Nocardia-like properties. There bacteriology. Typical cases of sarcoidosis may be treated for tuberculosis following the discovery of acid fast orhave been several case reports of Nocardia asteroides infection in cases with end stage sarcoidosis but these ganisms that are later found to be culture negative or that are only positive in one out of numerous samples. 32 33 are likely to be an unrelated late complication. 23 Acid fast coccobacillary bacteria have been identified in tissue
There are case reports of tuberculosis preceding or following sarcoidosis and even occurring concurrently. [34] [35] [36] [37] from cases of sarcoidosis and it has been suggested that corynebacteria may be a causal agent. Non-diphtheria Although patients with sarcoidosis often have depressed type IV delayed hypersensitivity responses to recall anticorynebacteria may produce a clinical syndrome resembling sarcoidosis with lymphadenitis, pneumonitis, gens, skin testing as a discriminator for disease can be misleading as there are patients with sarcoidosis who and skin lesions 24 25 but there have been no studies providing further evidence to implicate this organism.
respond to tuberculin. 34 Furthermore, there are reports of bacteriologically proven tuberculosis unresponsive to Mycoplasma like organisms (MLO) are obligate intracellular cell wall deficient bacteria and are a common antituberculous treatment despite good in vitro sensitivities to antituberculous drugs that subsequently showed cause of transmissible plant diseases. Recently these organisms have been detected by electron microscopy improvement following corticosteroids. 34 Several mechanisms by which undetected mycowithin leucocytes in sterile aqueous and vitreous fluid from patients with uveitis secondary to sarcoidosis. 26 MLO bacteria may produce the clinical and histological changes of sarcoidosis have been put forward. Following have also been described as inducing pulmonary syndromes similar to sarcoidosis, 27 and injection of MLO from patients the discovery that a large number of patients with either tuberculosis or sarcoidosis had mycobacteriophage inwith uveitis into murine eyelids can produce uveitis and systemic granulomatous reactions. 28 More recently, MLO fection, Mankiewicz 38 suggested that tuberculosis infected patients normally produce mycobacteriophage have been identified in leucocytes and endothelial cells adjacent to granulomas within transbronchial biopsy specineutralising antibodies and that patients incapable of producing these antibodies -that is, patients with sarmens from patients with sarcoidosis. 28 Although these infective agents have been suggested coidosis -may develop non-caseating granulomas. Although there were some further experimental data from as being the cause of sarcoidosis, most studies of a possible causal organism have focused on mycobacteria.
the same group in support of this hypothesis, other investigators were not able to demonstrate an identifiable deficiency in neutralising antibody production to mycobacteriophages. Burnet 39 suggested that mycoMycobacteria Almenoff et al in the introductory article 29 have recently bacteria may be present in a protoplast or cell wall deficient L form persisting as an intracellular organism characterised acid fast cell wall deficient forms grown in the blood of patients with active sarcoidosis and have in mesenchymal cells which may be present in the epithelioid cells of non-caseating granulomas. Hanngren demonstrated that these are of mycobacterial origin using an antibody raised against Mycobacterium tuberreiterated the concept of interaction of virus and mycobacteria by suggesting that concurrent viral infection culosis whole cell antigen. These findings have again raised the possible link between mycobacteria and sardepressed T cell function and therefore altered the immune response to mycobacteria.
The T lymphocyte may play a central role in the sarcoidosis, using PCR, found expression of IS6110 (an insertion element specific for M tuberculosis) in initial immune response to a presumptive antigenic stimulus in sarcoidosis. T lymphocytes are capable of bronchoalveolar lavage fluid from half of their subjects but also demonstrated a high false positive rate in producing the characteristic granulomatous changes seen in sarcoidosis by elaboration of various immune their normal control subjects and therefore raised the possibility that some of the positive results may be due mediators.
41-43 T lymphocytes bearing receptors have also been found to be increased in the peripheral blood to contamination. Using a different primer they also showed evidence for the presence of non-tuberculous of patients with sarcoidosis. 44 These T lymphocytes appear to proliferate in the presence of mycobacterial mycobacteria in 20% of these samples. Fidler et al, 56 this time examining tissue from 16 subjects with sarantigen and, in particular, show an expansion of the V 2+ subsets 45 in both patients with tuberculosis and coidosis, 16 control subjects (squamous cell carcinoma, Hodgkin's disease), and four lung samples from tubersarcoidosis and may therefore reflect undetected infection in sarcoidosis.
culosis subjects, were able to demonstrate M tuberculosis DNA in seven of the 16 sarcoidosis samples but also in one of the 16 matched control group. Notably, only    two of the four positive control samples were positive. An infective or transmissible cause for sarcoidosis has They based a positive result on the demonstration of been supported by animal experiments where injection amplification of both IS6110 and the 65 kD gene maof sarcoid lymph node material into footpads of mice terial. Detection of the 65 kD antigen gene is less sensresulted in formation of granulomas when biopsy itive than that of IS6110 and hence this study may samples were taken 6-8 months later. Notably, acid fast potentially be underestimating the presence of M tuberorganisms were also found in some of these tissues. 17 culosis material. 31 The same response and detection of acid fast bacilli Although in general these studies using sensitive mocould also be produced by injecting pooled homogenates lecular tools have shown some evidence for the presence or supernatants of mouse granulomatous tissue into of mycobacteria in sarcoidosis, two studies have not further mice. These preparations had been filtered demonstrated any mycobacterial nucleic acid in sarcoid through a 0.2 m filter therefore implying that the tissue. Ghossein et al, 57 using a target sequence for the "transmissible" agent had to be the size of a virus or 65 kD antigen, did not detect any positive signal in fixed protoplast and notably could be inactivated by irtissues from 10 patients with sarcoidosis and 10 control radiation or autoclaving. Mycobacteria having the charsubjects although they were able to demonstrate positive acteristics of Mycobacterium tuberculosis were also grown signals from six patients with tuberculosis. Similarly, in Lö wenstein-Jensen medium from some of these Gerdes et al 58 found no evidence for a target sequence homogenates. Other animal studies have confirmed the not specific for M tuberculosis (16S rRNA) in 14 samples production of slow developing granulomas after the although all of their control group of six tuberculosis injection of sarcoid homogenates. 46 However, there still subjects were positive. remains some uncertainty about these experiments imSpecific studies have also attempted to address dirplicating mycobacterial infection as other investigators ectly the issue of whether these mycobacteria are have not been able to reproduce them. 16 atypical 59 60 but these have not been positive. It is notable, however, that the study by Saboor et al 55 detected that 20% of their sample may have represented atypical    mycobacteria by using a separate non-specific primer. A number of investigators have compared the level of antimycobacterial antibodies in patients with sarcoidosis, mycobacterial infection, and control subjects 47 48 but these Introductory article investigations have led to differing results. 49 50 In the introductory article Almenoff et al 29 have cultured acid fast cell wall deficient forms (CWDF) or "L forms" from blood of patients with active sarcoidosis and have   Several studies investigating the presence of mycocharacterised these as being likely to be Mycobacterium tuberculosis in origin by using a monoclonal antibody bacterial DNA employing molecular biological techniques have been carried out in sarcoidosis. A review against whole cell antigen (H 37 RV). "L form" is a term used to describe spheroblasts of the techniques and various molecular studies have been comprehensively described. 31 (atypical morphological forms derived from classical bacteria that have lost their rigidity due to cell wall In a study using liquid in situ hybridisation Mitchell et al 51 extracted RNA from five normal subjects and five deficiency) that are capable of giving rise to typical "L colonies" with a "fried egg" appearance on agar. 61 These patients with sarcoidosis. Using a DNA probe specific for ribosomal RNA of Mycobacterium tuberculosis they CWDF may have the capacity to persist for longer as a possible consequence of loss of membrane receptors for demonstrated a significantly higher expression of mycobacterial nucleic acid in splenic tissue of subjects with phagocytosis. There is no definite evidence that these L forms are pathogenic but they may revert back to the sarcoidosis than normal controls. Bocart et al 52 used the polymerase chain reaction (PCR) to detect DNA parent form at a slow rate and therefore maintain disease at a subclinical level. 62 An additional factor favouring encoding for the 65 kD mycobacterial antigen and detected this in three out of 14 biopsy samples. Popper et the role of CWDF in sarcoidosis is that they are harder to detect by conventional culture and are also capable al 53 also found similar results in a group of sarcoidosis patients with two out of 15 cases demonstrating positive of producing filterable sized organisms. CWDF 63 have been described in tissue from subjects with sarcoidosis signals (compared with all 24 tuberculosis subjects). Thakker et al 54 reported a single positive result from for some time [64] [65] [66] and have been thought most likely to be mycobacterial in nature. In addition, these CWDF lymph node biopsy specimens but the authors suspected that this was due to contamination.
have been cultured from blood, 67 skin, 60 bronchial washings, and ocular anterior chamber fluid from patients Higher detection rates have been found in two other studies. Saboor et al, 55 in a study of 22 subjects with with sarcoidosis. 68 Previous experimental studies of group.bmj.com on October 14, 2017 -Published by http://thorax.bmj.com/ Downloaded from jugated goat anti-mouse antibody they identified positive binding of H 37 RV by fluorescence microscopy. All the identified CWDF appeared to stain positively with the antibody and were therefore felt to be mycobacterial in origin and most likely to be M tuberculosis. The authors point out that further DNA analysis of these L forms may allow further characterisation and differentiation of M tuberculosis and other atypical mycobacteria.
    
Although there appears to be some evidence for the presence of mycobacteria in patients with sarcoidosis, this does not necessarily imply a causal pathogenetic relationship and therefore these findings should still be interpreted with caution pending further confirmatory studies. Currently the most positive molecular studies have only detected mycobacterial DNA in 50% of cases, raising the possibility of some other uncharacterised the lack of control subjects for the effect of corticosteroids. It may be argued that corticosteroids are merely allowing increased proliferation of mycobacteria in these intraperitoneal injections of CWDF, grown from blood subjects and that the increased detection of mycoof patients with sarcoidosis, demonstrated production bacteria or L forms is a "bystander" effect. of granulomatous lesions in lung, liver, kidney, spleen,
The treatment of sarcoidosis with corticosteroids has and eyes in mice, gerbils, and guinea pigs. 69 More not resulted in an increase in mycobacterial infection. recently a study by Alavi et al 70 has characterised these Furthermore, previous studies examining the effect of CWDF in sarcoidosis tissues as being mainly M tuberantituberculous therapy in sarcoidosis have not shown culosis in origin by the use of specific antibodies.
any efficacy, although the role of mycobacterial infection Almenoff et al 29 studied 20 subjects with clinical may be through an initiation of an "overexuberant" evidence of sarcoidosis whose sputum was negative for immune process and may not be required to continue acid fast bacilli on smear and culture. All these subjects this process. There has not been any consistent epihad pulmonary disease but three also had skin disease, demiological evidence for an increase in sarcoidosis in one joint disease, and one had neurological involvement.
areas with an increased prevalence of tuberculosis. 34 71 Seven were receiving systemic corticosteroids. Twenty Additionally, BCG vaccination has not been shown to healthy control subjects were also studied and none had reduce the incidence of sarcoidosis. Cultures of peripheral blood from all subjects were examined by microscopy using a modified Kinyoun stain by blinded investigators. Cell wall deficient bacteria Conclusion The aetiology of sarcoidosis still remains undetermined. were identified in 19 out of the 20 sarcoidosis subjects whereas none were identified in the control subjects.
However, given the recent molecular studies and the findings of the introductory article, the evidence for a The authors then went on to characterise these CWDF by the use of a mouse monoclonal antibody developed possible role of mycobacteria in the pathogenesis of this disease is still emerging and warrants further evaluation. against M tuberculosis H 37 RV whole cell antigen (fig 1) . Previous experiments had shown that this antibody was
In the introductory article Almenoff et al add support for the role of mycobacteria in the pathogenesis of relatively specific for H 37 RV, BCG, and H 37 RA antigens with little binding to atypical mycobacteria and no sarcoidosis. The studies to date have been variable in their findings and more extensive controlled studies are binding to other Gram positive or negative bacteria. By the use of a second fluorescein isothiocyanate-conrequired with standardisation of the molecular tech-LEARNING POINTS * The aetiology of sarcoidosis is still uncertain. * There is accumulating evidence for the role of mycobacteria in patients with sarcoidosis. * The finding of cell wall deficient forms goes some way to explaining previous conflicting data on the role of mycobacteria in sarcoidosis.
